UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

European journal of cancer (1990), 2004-02, Vol.40 (3), p.383-389

2004

Volltextzugriff (PDF)

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

Leukemia, 2017-05, Vol.31 (5), p.1240-1243

2017

Volltextzugriff (PDF)

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia

Leukemia, 2001-10, Vol.15 (10), p.1510-1516

2001

Volltextzugriff (PDF)

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias

Neoplasma, 2005, Vol.52 (4), p.318

2005

Volltextzugriff (PDF)

Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine

British journal of haematology, 2001-03, Vol.112 (4), p.1083-1085

2001

Volltextzugriff (PDF)

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients

British journal of haematology, 2000-02, Vol.108 (2), p.357-368

2000

Volltextzugriff (PDF)

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

Neoplasma, 2002, Vol.49 (3), p.145

2002

Volltextzugriff (PDF)

The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast

Journal of experimental & clinical cancer research, 2000-03, Vol.19 (1), p.61-67

2000

Volltextzugriff (PDF)

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2‐CdA): an unusual variant of Richter's syndrome

European journal of haematology, 2001-11, Vol.67 (5‐6), p.322-327

2001

Volltextzugriff (PDF)

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells

Advances in experimental medicine and biology, 2000, Vol.486, p.307

2000

Volltextzugriff (PDF)

P632: ORAL AND GUT MICROBIAL DIVERSITY CORRELATES WITH PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA

HemaSphere, 2022-06, Vol.6, p.530-531

2022

Volltextzugriff (PDF)

Activity of Cladribine Combined with Etoposide in Heavily Pretreated Patients with Indolent Lymphoid Malignancies

Chemotherapy (Basel), 2005-08, Vol.51 (5), p.247-251

2005

Volltextzugriff (PDF)

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger

Leukemia, 1999-04, Vol.13 (4), p.518-523

1999

Volltextzugriff (PDF)

Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias

International journal of hematology, 1996-04, Vol.63 (3), p.193-203

1996

Volltextzugriff (PDF)

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission

Mediators of Inflammation, 1999-01, Vol.1999 (6), p.277-286

1999

Volltextzugriff (PDF)

A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients

Neoplasma, 1998, Vol.45 (4), p.216

1998

Volltextzugriff (PDF)

Richter's Syndrome Following Cladribine Therapy for Chronic Lymphocytic Leukemia First Manifested as Pathologic Fracture of the Femur

Leukemia & lymphoma, 2001, Vol.42 (4), p.789-796

2001

Volltextzugriff (PDF)

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

International journal of oncology, 2015-03, Vol.46 (3), p.1259-1267

2015

Volltextzugriff (PDF)

In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone

Oncology reports, 2006-12, Vol.16 (6), p.1389-1395

2006

Volltextzugriff (PDF)

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

European journal of cancer (1990), 1997-12, Vol.33 (14), p.2347-2351

1997

Volltextzugriff (PDF)

Does Intensive Treatment with High Dose Chlorambucil and Prednisone as First Line and Cladribine as Second Line Influence the Survival of the Patients with Chronic Lymphocytic Leukemia?

Leukemia & lymphoma, 2001, Vol.41 (5-6), p.545-557

2001

Volltextzugriff (PDF)

Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias

Neoplasma, 2002, Vol.49 (5), p.295

2002

Volltextzugriff (PDF)

Low-Grade Non-Hodgkin's Lymphoma in a Patient with Systemic Lupus Erythematosus

Leukemia & lymphoma, 2001, Vol.41 (5-6), p.659-667

2001

Volltextzugriff (PDF)

Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease

Neoplasma, 1998, Vol.45 (3), p.140

1998

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(55)
Tagungsberichte
(1)

Sprache

Englisch
(54)
Polnisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(49)
Science & Technology
(47)
Life Sciences & Biomedicine
(44)
Female
(37)
Middle Aged
(37)
Aged
(35)
Male
(33)
Oncology
(26)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(23)
Adult
(21)
Hematology
(19)
Aged, 80 And Over
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Cladribine
(14)
Cladribine - Administration & Dosage
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Chronic Lymphocytic Leukemia
(12)
Hematologic And Hematopoietic Diseases
(9)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias

Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2‐CdA): an unusual variant of Richter's syndrome

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells

P632: ORAL AND GUT MICROBIAL DIVERSITY CORRELATES WITH PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA

Activity of Cladribine Combined with Etoposide in Heavily Pretreated Patients with Indolent Lymphoid Malignancies

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger

Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission

A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients

Richter's Syndrome Following Cladribine Therapy for Chronic Lymphocytic Leukemia First Manifested as Pathologic Fracture of the Femur

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

Does Intensive Treatment with High Dose Chlorambucil and Prednisone as First Line and Cladribine as Second Line Influence the Survival of the Patients with Chronic Lymphocytic Leukemia?

Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial

Low-Grade Non-Hodgkin's Lymphoma in a Patient with Systemic Lupus Erythematosus

Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease

Suchergebnisse filtern